Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05923775
Other study ID # 2021/197
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2023
Est. completion date September 15, 2023

Study information

Verified date September 2023
Source TC Erciyes University
Contact Cihan Topan, Doctor
Phone 05556456587
Email cihantopan@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of the clinical trial is to compare the efficacy of ibuprofen, ketamine, and their combination in managing postoperative pain and trismus following third molar surgery. The main question it aims to answer is: which is the best way to control pain and trismus after third molar surgery?


Description:

Materials and methods The study will comprise 100 individuals who requested to have their mandibular third molar tooth extracted at the Erciyes University Faculty of Dentistry. Participants were randomly allocated into four groups, with 25 patients in each group. The first group (Intrafen group): Each patient in this group will be administered intravenous Ibuprofen (400 mg/8 ml i.v. infusion) for pre-emptive analgesic effect 60 minutes before surgical third molar extraction. Before the procedure, patients will be given local anesthesia using a mixture of 2 ml of local anesthetic (Ultracain Ds Fort 2 ml) plus 3 ml of saline solution (Poliflex 0.9% isotonic 100 ml solution). The impacted third molars of the patients will be removed. The second group (Ketamine group): Each patient in this group will be administered intravenous 100 ml saline (Poliflex 0.9% isotonic 100 ml solution) for a placebo effect 60 minutes before surgical third molar extraction. Before the procedure, patients will be given local anesthesia using a mixture of 2 ml of local anesthetic (Ultracain Ds Fort 2 ml) plus 3 ml of saline solution (Poliflex 0.9% isotonic 100 ml solution) plus 0,3 mg/kg of ketamine (Ketalar 500 mg). The impacted third molars of the patients will be removed. The third group (Combined group): Each patient in this group will be administered intravenous Ibuprofen (400 mg/8 ml i.v. infusion) for pre-emptive analgesic effect 60 minutes before surgical third molar extraction. Before the procedure, patients will be given local anesthesia using a mixture of 2 ml of local anesthetic (Ultracain Ds Fort 2 ml) plus 3 ml of saline solution (Poliflex 0.9% isotonic 100 ml solution) plus 0,3 mg/kg of ketamine (Ketalar 500 mg). The impacted third molars of the patients will be removed. The fourth group (Control group): Each patient in this group will be administered intravenous 100 ml saline (Poliflex 0.9% isotonic 100 ml solution) for a placebo effect 60 minutes before surgical third molar extraction. Before the procedure, patients will be given local anesthesia using a mixture of 2 ml of local anesthetic (Ultracain Ds Fort 2 ml) plus 3 ml of saline solution (Poliflex 0.9% isotonic 100 ml solution). The impacted third molars of the patients will be removed.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 15, 2023
Est. primary completion date September 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - Patients with a fully embedded third molar tooth in the mandible - Patients with regular attendance for routine follow up - Patients with a healthy general systemic condition Exclusion Criteria: - Patients with a fully erupted or partially embedded third molar tooth in the mandible - Patients who have previously experienced allergies to NSAIDs, local anesthetics, and ketamine - Pregnant or breastfeeding patients - Patients who have recently used a different group of NSAIDs for a different condition

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Impacted third molar surgey
The surgery was performed using the classic technique: ten minutes after anesthesia administration, a horizontal and sulcular incision was performed, and a mucoperiosteal envelope flap was elevated. The bone covering the impacted third molar tooth was removed with the use of a surgical handpiece and rotary instrument. During the operation, saline water was applied to the surgical drill with a second hand to protect the bone from developing a high temperature. After extraction of the third molar, the cavity was treated with curettage, irrigated with saline, and sutured.

Locations

Country Name City State
Turkey Erciyes University Faculty of Dentistry Kayseri

Sponsors (2)

Lead Sponsor Collaborator
Cihan Topan TC Erciyes University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary The pain level measurement after impacted third molar surgery will be assessed with the visual analog scale (VAS) in all groups. VAS (Pain intensity was assessed on a 100-mm visual analoge scale, where 0=no pain and 100=worst possible pain) The pain level measurements of all patients will be evaluated by a visual analog scale (VAS) two hours following impacted third molar surgery. [All study participants were asked to record their pain levels two hours after surgery].
Primary The pain level measurement after impacted third molar surgery will be assessed with the visual analog scale (VAS) in all groups. VAS (Pain intensity was assessed on a 100-mm visual analoge scale, where 0=no pain and 100=worst possible pain) The pain level measurements of all patients will be evaluated by a visual analog scale (VAS) six hours following impacted third molar surgery. [All study participants were asked to record their pain levels six hours after surgery].
Primary The pain level measurement after impacted third molar surgery will be assessed with the visual analog scale (VAS) in all groups. VAS (Pain intensity was assessed on a 100-mm visual analoge scale, where 0=no pain and 100=worst possible pain) The pain level measurements of all patients will be evaluated by a visual analog scale (VAS) 12 hours following impacted third molar surgery. [All study participants were asked to record their pain levels 12 hours after surgery].
Primary The pain level measurement after impacted third molar surgery will be assessed with the visual analog scale (VAS) in all groups. VAS (Pain intensity was assessed on a 100-mm visual analoge scale, where 0=no pain and 100=worst possible pain) The pain level measurements of all patients will be evaluated by a visual analog scale (VAS) 24 hours following impacted third molar surgery. [All study participants were asked to record their pain levels 24 hours after surgery].
Primary The limitation of mouth opening (trismus) after third molar surgery will be measured in all groups. Trismus was evaluated preoperatively by measuring the distance between the mesial-incisal corners of the upper and lower right central incisors at the maximum opening of the jaws. The limitation of mouth opening (trismus) after third molar surgery will be measured in all groups. [The maximum mouth opening of all study participants will be measured and recorded before surgery].
Primary The limitation of mouth opening (trismus) after third molar surgery will be measured in all groups Trismus was evaluated on the second day postoperatively by measuring the distance between the mesial-incisal corners of the upper and lower right central incisors at the maximum opening of the jaws. The limitation of mouth opening (trismus) after third molar surgery will be measured in all groups. [The maximum mouth opening of all study participants will be measured and recorded two days after the surgery].
Primary The limitation of mouth opening (trismus) after third molar surgery will be measured in all groups Trismus was evaluated on the seventh day postoperatively by measuring the distance between the mesial-incisal corners of the upper and lower right central incisors at the maximum opening of the jaws. The limitation of mouth opening (trismus) after third molar surgery will be measured in all groups. [The maximum mouth opening of all study participants will be measured and recorded seven days after the surgery].
Secondary The secondary outcome measure is the amount of rescue analgesia used by all participants after impacted third molar tooth surgery. All study participants will record the dose of rescue analgesic medicine (Paracetamol 500 mg) at home if they need to take it within 24 hours following surgery. The mean amount of rescue analgesia used by all participants within the first 24 hours after surgery will be calculated.
See also
  Status Clinical Trial Phase
Recruiting NCT05722509 - Evaluation of a New Technique for Periodontal Pocket Reduction in the Extraction of Wisdom Teeth N/A
Completed NCT05992233 - "Effectiveness of Dual-Wavelength Laser Therapy in Third Molar Extraction Pain, Swelling, and Trismus" N/A
Not yet recruiting NCT05924191 - Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars N/A
Withdrawn NCT05374993 - An Early Feasibility Evaluation of a Novel 3rdMolarTooth Bud Ablation Procedure N/A
Completed NCT04182191 - Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam Phase 4
Completed NCT04203771 - Probiotic Intervention After Surgical Removal of Mandibular Third Molars N/A
Recruiting NCT05941130 - 3D Evaluation of Postoperative Edema After Third Molar Surgery Phase 4
Completed NCT04033744 - Prevention of Mandibular Third Molar Extraction- Associated Periodontal Defects Using Platelet-Rich Fibrin N/A
Completed NCT00154518 - The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement Phase 1
Active, not recruiting NCT06073535 - The Use of Injectable-Platelet Rich Fibrin (i-PRF) in the Lower Third Molar Extraction N/A
Completed NCT03545022 - Acupuncture on Anxiety and Inflammatory Events Following Surgery of Mandibular Third Molars N/A
Completed NCT02890680 - Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery N/A
Recruiting NCT02284841 - Effect of Hilotherm Therapy on Post-operative Pain and Swelling Following Surgical Wisdom Tooth Removal N/A
Recruiting NCT01896427 - Comparing Pain and Swelling After Surgical Extraction of Mandibular Third Molar in Dexamethasone Injection and Without Corticosteroid Methods Phase 4
Enrolling by invitation NCT03567369 - 92/5000 Preoperative Efficacy of Traumeel Versus Dexamethasone in the Control of Pain, Swelling and Trismus N/A